High-frequency KRAS mutations in pancreatic adenocarcinoma: prognostic significance and potential co-targeting therapies
KRAS mutations serve as independent prognostic risk factors in PAAD, and targeting these mutations may offer a promising therapeutic approach to improve patient outcomes.
Authors
- Jinlong Yu (ORCID: https://orcid.org/0000-0002-5234-9285)
- Xiaorui Liu (ORCID: https://orcid.org/0000-0003-0683-6872)
- Dongmei Yan (ORCID: https://orcid.org/0000-0003-3652-4394)
- Xiaoshi Zhang (ORCID: https://orcid.org/0000-0002-3735-2021)
Institutions
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-04-01
- DOI
- https://doi.org/10.21037/tcr-24-1832
- Citations
- 3
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 3.14